 |
|
The Effect of Tetrahydroisoxazolopyridinol (THIP) in Tardive DyskinesiaA New β-Aminobutyric Acid Agonist
Søren Korsgaard, MD;
Daniel E. Casey, MD;
Jes Gerlach, MD;
Ole Hetmar, MD;
Bjørn Kaldan, MD;
Leif B. Mikkelsen, MD
Arch Gen Psychiatry. 1982;39(9):1017-1021.
Abstract
• β-Aminobutyric acid (GABA) agonists have been proposed for the treatment of tardive dyskinesia, but their therapeutic potential has been limited by side effects and toxicity. To elucidate further the role of GABA in neuroleptic-induced dyskinesias, we evaluated tetrahydroisoxazolopyridinol (THIP), a new, less toxic GABA analog and GABA receptor agonist, in both a dose-finding (single-dose) pilot study with five patients and a longer (four-week) placebo-controlled study with 13 patients. The patients were videotaped during a standardized examination; tardive dyskinesia, parkinsonian symptoms, and eye-blinking rates were rated blindly and randomly. The maximal shortterm dose of THIP was 10 to 25 mg, whereas in the longer-term study the highest daily dose ranged from 20 to 120 mg. Tardive dyskinesia was unchanged during THIP treatment, but preexisting parkinsonism increased significantly and eye-blinking rates decreased. Psychiatric symptoms showed no significant changes, although tension and depression lessened. Side effects included sedation, confusion, dizziness, vomiting, and myoclonic jerks. Although THIP is not an effective new treatment for tardive dyskinesia, more specific GABA agonists should be evaluated in future studies of this syndrome.
Author Affiliations
From Departments H (Drs Korsgaard, Casey, and Gerlach), D (Dr Kaldan), E (Dr Hetmar), and F (Dr Mikkelsen), Set Hans Mental Hospital, Roskilde, Denmark, and the Medical Research, Psychiatry, and Neurology Services, Veterans Administration Medical Center, Portland, Ore (Dr Casey), and the School of Medicine, Oregon Health Sciences University, Portland (Dr Casey).
Footnotes
Accepted for publication Dec 31, 1981.
Reprint requests to Department H, Set Hans Mental Hospital, DK-4ö00 Roskilde, Denmark (Dr Korsgaard).
 CiteULike  Connotea  Delicious  Digg  Facebook  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Brain {gamma}-Aminobutyric Acid Abnormality in Tardive Dyskinesia: Reduction in Cerebrospinal Fluid GABA Levels and Therapeutic Response to GABA Agonist Treatment
Thaker et al.
Arch Gen Psychiatry 1987;44:522-529.
ABSTRACT
|
